Clovis Oncology (CLVS) Stock: The Low Down On Approval

Clovis Oncology (NASDAQ:CLVS) On Monday, Clovis Oncology stock closed higher by 9% after it announced that the FDA had approved its drug. The drug in question is known as rucaparib – to be marketed as Rubraca. This was for early approval of rucaparib, which is used to treat patients with advanced ovarian cancer. The stock … Read more

Biotech Stock News (INO) (NYMX)

Inovio Pharmaceuticals (NASDAQ:INO) On Monday June 20, 2016 Inovio Pharmaceuticals along with one of its subsidiaries Gene One Life Sciences have received authorization from the FDA to begin a first ever trial in humans targeting the Zika Virus. This is a monumental event, because it will the first trial ever to begin treating humans with … Read more

Biotech Stock News (SRPT)(SPHS)

Sarepta Therapeutics (NASDAQ:SRPT) On Monday June 6, 2016 shares of Sarepta Therapeutics were up more than 31% in after-hours trade after the company announced that the FDA had requested for additional data for the Eteplirsen decision. The market clearly viewed the fact that the FDA needed more data as a positive. Which is why shares … Read more

Biotech Stock News (IMGN) (RGLS) (GILD) (ACHN) (OPK) (BRLI)

Immunogen (NASDAQ:IMGN) Shares of Immunogen soared as much as 68% on June 1, 2015 after the company reported positive results in patients with platinum-resistant ovarian cancer. There are about 21,290 cases of women who get ovarian cancer in the United States each year. The problem is that a lot of these patients that take chemotherapy … Read more